Amita Moirangthem1, Shubha R Phadke2. 1. Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India. 2. Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India. shubharaophadke@gmail.com.
Abstract
OBJECTIVE: To compile the socio-demographic profile and estimate the economic burden of transfusion dependent thalassemia. METHODS: This cross-sectional descriptive study was conducted at a tertiary care hospital in north India. Transfusion dependent thalassemia patients on regular blood transfusion for at least a year were selected. Thalassemia diagnosis was based on HPLC and/or mutation analysis results. Clinical and laboratory parameters were collected from electronic health records. Information regarding socio-economic profile and costs incurred, including indirect costs were collected by interviewing patients' guardians. The data was analyzed as a whole cohort and also in subgroups based on age. RESULTS: The data of 261 patients with a median age of 127 mo was collected. The median age at diagnosis was 9.8 mo. The total treatment expenses of a patient per year ranged from US$ 629 (INR 41,514) to US$ 2300 (INR 151,800), in the different age groups, at an average of US$ 1135 (INR 74,948). More than half (53%) of this was spent on medications. On an average, 38.8% of the family income was spent on the treatment of a thalassemia patient annually. Only 19 of 262 cases had an average pre-BT Hb ≥ 9 g/dl and serum ferritin ≤1500 ng/dl. CONCLUSIONS: The treatment for transfusion dependent thalassemia is costly and mostly borne by the families in India. This study provides a realistic magnitude of this burden and will be useful in planning a thalassemia management program at the state or national level.
OBJECTIVE: To compile the socio-demographic profile and estimate the economic burden of transfusion dependent thalassemia. METHODS: This cross-sectional descriptive study was conducted at a tertiary care hospital in north India. Transfusion dependent thalassemiapatients on regular blood transfusion for at least a year were selected. Thalassemia diagnosis was based on HPLC and/or mutation analysis results. Clinical and laboratory parameters were collected from electronic health records. Information regarding socio-economic profile and costs incurred, including indirect costs were collected by interviewing patients' guardians. The data was analyzed as a whole cohort and also in subgroups based on age. RESULTS: The data of 261 patients with a median age of 127 mo was collected. The median age at diagnosis was 9.8 mo. The total treatment expenses of a patient per year ranged from US$ 629 (INR 41,514) to US$ 2300 (INR 151,800), in the different age groups, at an average of US$ 1135 (INR 74,948). More than half (53%) of this was spent on medications. On an average, 38.8% of the family income was spent on the treatment of a thalassemiapatient annually. Only 19 of 262 cases had an average pre-BT Hb ≥ 9 g/dl and serum ferritin ≤1500 ng/dl. CONCLUSIONS: The treatment for transfusion dependent thalassemia is costly and mostly borne by the families in India. This study provides a realistic magnitude of this burden and will be useful in planning a thalassemia management program at the state or national level.
Authors: B Sangani; P K Sukumaran; C Mahadik; H Yagnik; S Telang; F Vas; R A Oberroi; B Modell; S M Merchant Journal: Bull World Health Organ Date: 1990 Impact factor: 9.408
Authors: Parag M Tamhankar; Sarita Agarwal; Vandana Arya; Ravindra Kumar; U R Gupta; S S Agarwal Journal: Prenat Diagn Date: 2009-01 Impact factor: 3.050
Authors: Luciana Scalone; Lorenzo G Mantovani; Marieke Krol; Diana Rofail; Simona Ravera; Maria Grazia Bisconte; Caterina Borgna-Pignatti; Zelia Borsellino; Paolo Cianciulli; Domenico Gallisai; Luciano Prossomariti; Ippazio Stefàno; Maria D Cappellini Journal: Curr Med Res Opin Date: 2008-05-27 Impact factor: 2.580
Authors: D Mohanty; R B Colah; A C Gorakshakar; R Z Patel; D C Master; J Mahanta; S K Sharma; U Chaudhari; M Ghosh; S Das; R P Britt; S Singh; C Ross; L Jagannathan; R Kaul; D K Shukla; V Muthuswamy Journal: J Community Genet Date: 2012-10-21